Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study finds
(NEW YORK) -- A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature.Pancreatic cancer is one of the most aggressive cancers, with a typical survival rate of only about... Read More.